| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/14/2009 | CN100451034C Pig gamma interferon and encoding genes and use thereof |
| 01/14/2009 | CN100451033C Gene for inhibiting human transcription factor AP-1, its encoding polypeptide and uses |
| 01/14/2009 | CN100450552C Vaccine for diabetes in type I, and constructing method |
| 01/14/2009 | CN100450551C Recombinated adeno-associated virus genes vaccine for prevention and cure of Alzheimer disease and use thereof |
| 01/13/2009 | US7476728 Flea GABA receptor subunit nucleic acid molecules |
| 01/13/2009 | US7476721 Modified cytokines for use in cancer therapy |
| 01/13/2009 | US7476720 Rat neurotrophic factor receptor, GFR α-4 |
| 01/13/2009 | US7476654 Administering truncated, homodimeric platlet-derived growth factor-DD optionally with a vascular endothelial growth factor; reduce the leakage of leaky vessels by stimulating the proliferation and migration of smooth muscle cells; wound healing |
| 01/13/2009 | US7476539 DNA containing variant FRT sequences |
| 01/13/2009 | US7476536 Artificial human chromosome containing human antibody a light chain gene |
| 01/13/2009 | US7476401 Noncovalent interaction of a charged polypeptide with a surfactant of opposite charge to form a polypeptide-surfactant mixture; lyophilizing to form a dried salt complex; for delivering a polypeptide |
| 01/13/2009 | US7476382 Reovirus for the treatment of neoplasia |
| 01/13/2009 | CA2263750C Use of a melanoma differentiation associated gene (mda-7) for reversing a cancerous phenotype |
| 01/08/2009 | WO2009006479A2 Methods and compositions for producing an adenovirus vector for use with multiple vaccinations |
| 01/08/2009 | WO2009006300A2 Production cell lines for adenoviral manufacturing |
| 01/08/2009 | WO2009005868A2 Methods and devices for detecting binding events via zeta-potential and pharmacologically active compounds and delivery systems identified thereby |
| 01/08/2009 | WO2009005793A2 Tissue specific peptide conjugates and methods |
| 01/08/2009 | WO2009005142A1 Method for diagnosis of malignancy of gastrointestinal stromal tumor whose primary lesion is in stomach |
| 01/08/2009 | WO2009004995A1 Method of fixing and expressing physiologically active substance |
| 01/08/2009 | WO2009004575A2 Cartilage-specific expression |
| 01/08/2009 | WO2009003211A1 Treatment of rheumatoid arthritis |
| 01/08/2009 | WO2008112701A3 G-substrate for the treatment and prevention of parkinson's disease |
| 01/08/2009 | WO2008106646A3 Methods and formulations for topical gene therapy |
| 01/08/2009 | US20090013420 Psmcs as Modifiers of the Rb Pathway and Methods of Use |
| 01/08/2009 | US20090012280 Oligonucleotide compound and method for treating nidovirus infections |
| 01/08/2009 | US20090012270 Ox2 receptor homologs |
| 01/08/2009 | US20090012033 Delivery of Biologically Active Materials Using Core-Shell Tecto(Dendritic Polymers) |
| 01/08/2009 | US20090012021 Delivery of Sirna by Neutral Lipid Compositions |
| 01/08/2009 | US20090012020 Inhibiting formation of atherosclerotic lesions |
| 01/08/2009 | US20090011434 Methods And Compositions For Diagnosing Breast Cancer |
| 01/08/2009 | US20090011040 Use of compacted nucleic acid nanoparticles in non-viral treatments of ocular diseases |
| 01/08/2009 | US20090011036 Drug containing hollow protein nanoparticles of particle-forming protein, fused with disease-treating target-cell-substance |
| 01/08/2009 | US20090011003 Composition for Suppressing Expression of Target Gene |
| 01/08/2009 | US20090010967 Clostridial toxin derivatives and methods for treating pain |
| 01/08/2009 | US20090010961 Avirulent, immunogenic flavivirus chimeras |
| 01/08/2009 | US20090010950 Ex-vivo isolated cd25+cd4+ t cells with immunosuppressive activity and uses thereof |
| 01/08/2009 | US20090010938 Short immunomodulatory oligonucleotides |
| 01/08/2009 | US20090010936 Novel Stra6 Polypeptides |
| 01/08/2009 | US20090010935 Compositions and Methods of Treating Tumors |
| 01/08/2009 | US20090010917 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 01/08/2009 | US20090010901 adipocytes stably maintain a foreign gene encoding a protein that is secreted outside of cells; cells suitable for gene therapy, which can replace bone marrow cells and liver cells used for conventional ex vivo gene therapy |
| 01/08/2009 | US20090010894 Methods and systems for identifying compounds that modulate alpha-synuclein aggregation |
| 01/08/2009 | US20090010889 Treatment Using Herpes Simplex Virus |
| 01/08/2009 | US20090010842 Methods for the early diagnosis of ovarian cancer |
| 01/08/2009 | DE102007031417A1 Hyaluronate lyase with a histidine tag e.g. useful in pharmaceutical formulations and medical products |
| 01/08/2009 | CA2692287A1 Treatment of rheumatoid arthritis |
| 01/08/2009 | CA2691673A1 Tissue specific peptide conjugates and methods |
| 01/07/2009 | EP2011888A1 Nucleotide sequences resulting from the genome of the HIV-1, HIV-2 and SIV retroviruses, and their applications in particular for amplifying the genomes of these retroviruses and for in vitro diagnosis of infections caused by these viruses |
| 01/07/2009 | EP2011877A2 Conjugates for the modulation of immune responses |
| 01/07/2009 | EP2011875A1 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods |
| 01/07/2009 | EP2011874A1 Recombinant gelatin in vaccines |
| 01/07/2009 | EP2011862A1 Method for manufacturing an active component of a medicine or diagnosis agent in MDCJ cell suspension culture |
| 01/07/2009 | EP2011517A1 Polynucleotide binding complexes comprising sterols and saponin |
| 01/07/2009 | EP2010916A2 Novel tumour suppressor |
| 01/07/2009 | EP2010663A1 Exosome transfer of nucleic acids to cells |
| 01/07/2009 | EP1740600A4 Intracellular delivery of osteoinductive proteins and peptides |
| 01/07/2009 | EP1689872B1 Promoters for expression in modified vaccinia virus ankara |
| 01/07/2009 | EP1644492B1 Modified recombinant vaccinia viruses, uses thereof |
| 01/07/2009 | EP1587925A4 A process for delivering sirna to cardiac muscle tissue |
| 01/07/2009 | EP1455840B1 Treatment of human soft tissue sarcoma with adenoviral vector expressing tnf-alpha |
| 01/07/2009 | EP1231895B1 Modular targeted liposomal delivery system |
| 01/07/2009 | EP1212423B1 Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (pfemp1) that mediates adhesion to chondroitin sulfate a |
| 01/07/2009 | EP1200590B1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 01/07/2009 | EP1198581B1 Method for reducing the antigenicity of adeno-associated virus structural protein |
| 01/07/2009 | EP1012293B1 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 01/07/2009 | EP0971693B1 Method of making microencapsulated dna for vaccination and gene therapy |
| 01/07/2009 | EP0759985B1 Transgenic arthritic mice |
| 01/07/2009 | EP0662827B2 Diagnostic methods and pharmaceutical compositions based on notch proteins and nucleic acids |
| 01/07/2009 | CN101341246A The use of sirnas in organ storage/reperfusion solutions |
| 01/07/2009 | CN101338321A Method for constructing and screening miRNAs expression vector of stomach cancer target FUT3 gene and uses thereof |
| 01/07/2009 | CN101338313A Resistance gene of microtus fortis to schistosoma japonicum and encoded polypeptide thereof |
| 01/07/2009 | CN101338306A Method for treating cell proliferation hyperthyroidism based on anti-SURVIVIN ribozyme |
| 01/07/2009 | CN101338303A Adenovirus marked by radionuclide |
| 01/07/2009 | CN101338302A Recombination herpes simplex virus for tumor gene therapy |
| 01/07/2009 | CN101338284A Degradation strain capable of high-efficiency degrading bactericide chlorothalonil and use thereof |
| 01/07/2009 | CN101337076A Functional dendritic polymer gene vector system of targeted malignant cerebroma |
| 01/07/2009 | CN100448992C Artificial human chromosome containing human antibody lambda light chain gene |
| 01/07/2009 | CN100448892C Antitumour vascular endothelial growth factor receptor VEGF-R antigen and its coding gene and application |
| 01/07/2009 | CN100448845C Natural and synthetic isothiocyanate kind compound and its application in treating and preventing cancer |
| 01/06/2009 | US7473772 Chimeric GB virus B (GBV-B) |
| 01/06/2009 | US7473771 Nucleotide sequences coding recombinant protein for use in prevention and treatment of hyperphosphatemia |
| 01/06/2009 | US7473762 solid phase synthesis; for diagnosis/treatment/prophyaxis; animal models; genetic engineering |
| 01/06/2009 | US7473733 Cationic derivative of a water-soluble polysaccharide, cationic polyvinylalcohol, units derived from acrylic ester complexed with DNA; stable and soap-less latex; useful as a micro carrier for cell cultivation and immuno-adsorbent assay, gene transfer experiments, efficiency, transfection |
| 01/06/2009 | US7473679 Treatments employing neuronal exocytosis-inhibiting peptides |
| 01/06/2009 | US7473556 Aggregations; for use in the treatment of autoimune diseases; for use in immunotherapy; culturing embryonic stem cells in the presence of a cytokine or combination of cytokines which brings about differentiation of the embryonic stem cells into dendritic cells; recovering dendritic cells |
| 01/06/2009 | US7473536 To increase the titer of avipoxviruses produced from cells after infection of cells with the avipoxvirus, wherein the host range gene is expressed in cells |
| 01/06/2009 | US7473527 Compounds promoting delivery of genes |
| 01/06/2009 | US7473525 Rna; anticancer agents |
| 01/06/2009 | US7473419 Intravascular delivery of nucleic acid |
| 01/06/2009 | US7473418 Pan cancer oncolytic vectors and methods of use thereof |
| 01/06/2009 | US7473414 Using wound healing agent to repair injured nervous system tissues; gene therapy; animal models; tissue regeneration |
| 01/06/2009 | US7473247 Intradermal delivery of vaccines and gene therapeutic agents via microcannula |
| 01/06/2009 | CA2380231C Conditionally controlled, attenuated hiv vaccine |
| 01/06/2009 | CA2301403C High-throughput screening of gene function using libraries for functional genomics applications |
| 01/06/2009 | CA2179603C Production of pharmaceutical-grade plasmid dna |
| 01/06/2009 | CA2144406C Gene transcription and ionizing radiation: methods and compositions |
| 01/01/2009 | US20090007284 Transgenic organism |
| 01/01/2009 | US20090007280 Ange gene in atopy |
| 01/01/2009 | US20090005334 Nucleic acid derivatives |
| 01/01/2009 | US20090005333 Reducing culling in herd animals growth hormone releasing hormone (ghrh) |